These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31612732)

  • 1. Bilastine: a lifetime companion for the treatment of allergies.
    Church MK; Tiongco-Recto M; Ridolo E; Novák Z
    Curr Med Res Opin; 2020 Mar; 36(3):445-454. PubMed ID: 31612732
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.
    Church MK
    Expert Opin Drug Saf; 2011 Sep; 10(5):779-93. PubMed ID: 21831011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Sologuren A; Viñas R; Cordón E; Riesgo SE; Del Mar Forés M; Senán MR; Fernández S; Labeaga L; Ruiz-Miján M
    Allergy Asthma Proc; 2018 Jul; 39(4):299-304. PubMed ID: 29559031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilastine as a potential treatment in allergic rhinitis.
    Kowal K; DuBuske L
    Am J Rhinol Allergy; 2014; 28(4):312-6. PubMed ID: 25197918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
    Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK
    Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.
    Wang XY; Lim-Jurado M; Prepageran N; Tantilipikorn P; Wang de Y
    Ther Clin Risk Manag; 2016; 12():585-97. PubMed ID: 27110120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilastine: in allergic rhinitis and urticaria.
    Carter NJ
    Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
    Wolthers OD
    Biomed Res Int; 2013; 2013():626837. PubMed ID: 23956994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Bilastine in Allergic Rhinitis: A Narrative Review.
    Tiwaskar M; Vora A; Tewary K; Prakash A; Tripathi KK; Jain S; Ilambarati ; Pandit G; Singh BP
    J Assoc Physicians India; 2023 Nov; 71(11):58-61. PubMed ID: 38720498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.
    Rodríguez M; Vozmediano V; García-Bea A; Novák Z; Yáñez A; Campo C; Labeaga L
    Eur J Pediatr; 2020 May; 179(5):801-805. PubMed ID: 31919579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M; Yagami A; Togawa M; Saito A; Furue M
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
    Novák Z; Yáñez A; Kiss I; Kuna P; Tortajada-Girbés M; Valiente R;
    Pediatr Allergy Immunol; 2016 Aug; 27(5):493-8. PubMed ID: 26918853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abdelshafy AM; Abdallah SY; Hassan AF; Mohamed HA; Kamal NM; Ali ST; Abdelhaleem IA
    Am J Rhinol Allergy; 2022 Sep; 36(5):684-694. PubMed ID: 35593100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.